Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VANCOMYCIN Cause Disease recurrence? 116 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Disease recurrence have been filed in association with VANCOMYCIN (Vancomycin Hydrochloride). This represents 0.3% of all adverse event reports for VANCOMYCIN.

116
Reports of Disease recurrence with VANCOMYCIN
0.3%
of all VANCOMYCIN reports
10
Deaths
40
Hospitalizations

How Dangerous Is Disease recurrence From VANCOMYCIN?

Of the 116 reports, 10 (8.6%) resulted in death, 40 (34.5%) required hospitalization, and 6 (5.2%) were considered life-threatening.

Is Disease recurrence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VANCOMYCIN. However, 116 reports have been filed with the FAERS database.

What Other Side Effects Does VANCOMYCIN Cause?

Drug ineffective (4,938) Acute kidney injury (4,018) Drug reaction with eosinophilia and systemic symptoms (2,509) Off label use (2,070) Drug hypersensitivity (2,046) Pyrexia (1,596) Rash (1,461) Condition aggravated (1,189) Pruritus (958) Septic shock (766)

What Other Drugs Cause Disease recurrence?

NIRMATRELVIR\RITONAVIR (20,040) PREDNISONE (1,979) CYCLOPHOSPHAMIDE (1,689) RITUXIMAB (1,588) METHOTREXATE (1,401) DOXORUBICIN (980) VINCRISTINE (932) PREDNISOLONE (873) MYCOPHENOLATE MOFETIL (852) DEXAMETHASONE (784)

Which VANCOMYCIN Alternatives Have Lower Disease recurrence Risk?

VANCOMYCIN vs VANDETANIB VANCOMYCIN vs VARDENAFIL VANCOMYCIN vs VARENICLINE VANCOMYCIN vs VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN VANCOMYCIN vs VASOPRESSIN

Related Pages

VANCOMYCIN Full Profile All Disease recurrence Reports All Drugs Causing Disease recurrence VANCOMYCIN Demographics